Meloxicam Unichem

Meloxicam, the active ingredient in Meloxicam Unichem, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It alleviates pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Unichem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

- Osteoarthritis: decreases joint pain and swelling, helping improve function and quality of life. - Rheumatoid arthritis: mitigates synovial inflammation, reducing stiffness and joint damage progression. - Ankylosing spondylitis: lessens spinal pain and stiffness, supporting better mobility. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative states.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia, abdominal pain) - Headache - Dizziness - Elevated blood pressure - Peripheral edema - Skin rash or pruritus

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular events such as myocardial infarction or stroke - Acute renal failure or worsening of chronic kidney disease - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Hepatotoxicity (elevated liver enzymes, hepatitis) - Anaphylactic or anaphylactoid reactions

Before initiating therapy, evaluate patient-specific risk factors and monitor regularly. - Renal function: assess baseline creatinine and monitor during treatment, especially in the elderly or dehydrated patients. - Cardiovascular risk: use caution in patients with hypertension, heart failure, or a history of thrombotic events. - Gastrointestinal history: avoid in patients with prior ulcer disease or bleeding unless gastroprotective measures are in place. - Concomitant medications: review for potential interactions that may increase bleeding or renal toxicity. - Pregnancy and lactation: safety not established; avoid unless clearly needed and prescribed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other selective COX‑2 inhibitors: additive gastrointestinal and cardiovascular toxicity. - Lithium: meloxicam can raise serum lithium concentrations. - Methotrexate: enhanced methotrexate toxicity, especially renal impairment. - Loop or thiazide diuretics: may reduce renal clearance of meloxicam.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Beta‑blockers: may affect blood pressure control. - SSRIs or SNRIs: modestly increased bleeding risk.